| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 04/24/2003 | WO2003033456A1 NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS |
| 04/24/2003 | WO2003033453A1 Dicarboxylic acid derivatives, their preparation and therapeutical use |
| 04/24/2003 | WO2003033097A2 Rotor-stator apparatus and process for the formation of particles |
| 04/24/2003 | WO2003032751A1 Alkanoyl l-carnitine metal salts and dietary supplements |
| 04/24/2003 | WO2003002489A3 Solid-phase electrophilic fluorination |
| 04/24/2003 | WO2002022553A3 Non-natural basic amino acids, their preparation and use |
| 04/24/2003 | US20030078427 Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/24/2003 | US20030078418 Useful potentiators of beta -lactam antibiotics; therapy |
| 04/24/2003 | US20030078417 For protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents; for therapy of phospholipase mediated injury, injury due to oxidation, and inflammation |
| 04/24/2003 | US20030078355 Tertiary amine methacrylate-based macromonomers and polymers |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/24/2003 | US20030078300 Fused bicyclic or tricyclic amino acids |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 04/24/2003 | CA2463686A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/24/2003 | CA2463685A1 Novel .beta.-phenyl-.alpha.-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 04/24/2003 | CA2462514A1 Dicarboxylic acid derivatives, their preparation and therapeutical use |
| 04/23/2003 | EP1303487A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 04/23/2003 | EP1109775B1 Hyperbranched compounds with a tetrafunctional central group and use of same |
| 04/23/2003 | EP1107945B1 Stable free-flowing solid chelants |
| 04/23/2003 | EP1021394B1 Process for the preparation of ferric chelate solutions of alkali metal polyamino succinic acids |
| 04/23/2003 | EP1005447B1 Method for producing long-chain glycine-n,n-diacetic acid derivatives |
| 04/23/2003 | EP0935606B1 Method for purification of recombinant proteins |
| 04/23/2003 | EP0904264B1 Compositions for increasing the mri contrast in visualising the digestive tract of patients |
| 04/23/2003 | EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor |
| 04/23/2003 | CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/23/2003 | CN1413202A Stereospecific hydrolysis of optically active esters |
| 04/23/2003 | CN1413186A Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 04/23/2003 | CN1413185A Substitued 1 and 2 naphthol mannich bases |
| 04/22/2003 | US6552222 Hydrolysis of acylamino acids |
| 04/22/2003 | US6552077 Kidney disorders |
| 04/22/2003 | US6552061 Amino acid derivatives and anti-inflammatory agents |
| 04/17/2003 | WO2003031391A1 New anhydrous crystalline forms of gabapentin |
| 04/17/2003 | WO2003031390A1 Highly concentrated aqueous solutions of n,n-dialkyl- glycines and process for preparation thereof |
| 04/17/2003 | WO2003031389A1 Abscisic acid biosynthesis inhibitor |
| 04/17/2003 | WO2002022622A3 Synthesis of 2-hydroxymethylglutamic acid and congeners thereof |
| 04/17/2003 | US20030073846 Aminoalcohol derivatives |
| 04/17/2003 | US20030070241 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 04/17/2003 | CA2462689A1 Inhibitor against biosynthesis of abscisic acid |
| 04/17/2003 | CA2462331A1 New anhydrous crystalline forms of gabapentin |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1301542A2 Process for obtaining bio-functional fractions from biomass |
| 04/16/2003 | EP1301502A1 Novel compounds and their use as glycine transport inhibitors |
| 04/16/2003 | EP1301463A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 04/16/2003 | EP1015436B1 Morpholinones as light stabilizers |
| 04/16/2003 | EP1007505B1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 04/16/2003 | EP0931053B1 Process for the preparation of substituted aromatic amino compounds |
| 04/16/2003 | CN1411442A Farnesyl transferase inhibitors |
| 04/16/2003 | CN1410437A Method of producing silk peptide, silk amino acid by acid hydrolysis of natural silk |
| 04/16/2003 | CN1410417A Preparation method of glycine |
| 04/16/2003 | CN1105704C Selected fungicides for control of take-all disease of plants |
| 04/16/2003 | CN1105703C Alpha-substituted phenylacetic acid derivative, process for producing same, and agricultural bactericide containing same |
| 04/15/2003 | US6548693 Nitriloxy derivatives of (R) and (S)-carnitine |
| 04/15/2003 | US6548688 Diammonium ruthenium diethylenethriaminepentaacetate or hydrates thereof and process for the preparation of both |
| 04/15/2003 | US6548684 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds |
| 04/15/2003 | US6548538 Potent peroxisome proliferator activated receptor (PPAR)-alpha-activating compounds; propionic acid 2-subsituted with an N-(phenylaminocarbonylalkyl), N-(2-furanylmethyl)aminoalkylphenyl group |
| 04/15/2003 | US6548523 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| 04/10/2003 | US20030069438 Method for the stereoselective synthesis of cyclic amino acids |
| 04/10/2003 | US20030069310 Salicylic acid salts of salmeterol |
| 04/10/2003 | US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 04/10/2003 | US20030069172 Enhancing solubility of iron amino acid chelates and iron proteinates |
| 04/09/2003 | EP1300392A1 Process for producing optically active alpha-amino acid and optically active alpha-amino acid amide |
| 04/09/2003 | EP1300391A1 Process for producing 3-amino-2-hydroxypropionic acid derivatives |
| 04/09/2003 | EP1299342A1 Method for producing 3,3-diarylpropylamines |
| 04/09/2003 | CN1409700A Process for preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties |
| 04/09/2003 | CN1408705A Process for synthesizing 6-18F-L-dopa |
| 04/09/2003 | CN1408704A Process for preparing acetyl levocarnitine hydrochlorate |
| 04/08/2003 | US6545029 Antiosteoporotic, antirestenotic, anticarcinogenic and antiatherosclerotic |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065016 Nordihydroguaiartic derivatives for use in treatment of tumors |
| 04/03/2003 | US20030064976 Reacting ammonium formate, aldehyde and alkyl isocyanate |
| 04/03/2003 | US20030064429 Generation of picornaviral viricides; prepare chemical intermediates, form ketoester, lyse enolate, acylate, recover viricide |
| 04/03/2003 | US20030064391 Preparation of sequences on substrate; obtain substrate, deposit on plate surface, incubate with activator, remove protective groups, recover biopolymer |
| 04/02/2003 | WO2002028821A2 Propionic acid derivatives with ppar-alpha activating properties |
| 04/02/2003 | EP1296921A1 Cyclic ketones, their preparation and their use in the synthesis of amino acids |
| 04/02/2003 | EP1052246B1 Fluorine-containing amino acid derivatives |
| 04/02/2003 | EP0934923B1 Optically active erythro-3-amino-2-hydroxybutyric esters and process for preparing said esters |
| 04/02/2003 | CN1407967A Stereoselective synthesis of cyclic amino acids |
| 04/02/2003 | CN1406927A Sodium glutamate preparation |
| 04/02/2003 | CN1104421C Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/02/2003 | CA2424540A1 Propionic acid derivatives with ppar-alpha activating properties |
| 04/01/2003 | US6541670 Antiinflammatory agents |
| 04/01/2003 | US6541663 As oxidation catalyst for amine-group-containing primary amines to carboxylic acids |
| 04/01/2003 | US6541641 Reacting a carbamate compound containing ester and hydroxy groups with thionyl chloride to form oxo-oxazoline derivatives; cyclization |
| 04/01/2003 | US6541473 Resorcinol derivatives |
| 04/01/2003 | US6541051 Preparation of metal complexes of amino acids obtained by hydrolysis of soy protein |
| 04/01/2003 | US6541016 Monoalkyl phosphoric esters, dialkyl phosphoric esters, and, in small amounts, trialkyl phosphoric esters or salts, based on beta-branched fatty alcohols, effective in lowering the surface tension of both polar and nonpolar liquids |
| 03/28/2003 | WO2002030871A1 Use of amino acids for treating pain |
| 03/28/2003 | CA2424089A1 Use of amino acids for treating pain |
| 03/27/2003 | WO2002014261A3 4-substituted d-glutamic acid derivatives for use as antibiotic |
| 03/27/2003 | US20030060657 Process for the preparation of Aceclofenac |
| 03/27/2003 | US20030060630 Method for the manufacture of Anagrelide |
| 03/27/2003 | DE20217570U1 Oxidative dyes for keratin fibers are based on a developer-coupler combination also containing (hetero)aromatic group-substituted 1,2-diaminobenzene derivatives, some of which are new compounds |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1295865A1 Novel dicarboxylic acid derivatives |
| 03/26/2003 | EP1294677A1 Benzophenones and sulfones as inhibitors of glycine uptake |
| 03/26/2003 | EP1294378A2 Thrombopoietin mimetics |
| 03/26/2003 | EP1294364A1 Stable gabapentin having ph within a controlled range |
| 03/26/2003 | EP1027325B1 Lipophilic diesters of chelating agents |
| 03/26/2003 | EP0950044A4 Preparation of gabapentin |